mergers & acquisitions
Schoenherr's international m&a experts provide straight to the point cross-border transactional and corporate commercial law advice. Throughout CEE/SEE the practice has consistently been ranked in the highest tier by acclaimed legal directories.
"Schoenherr continues to attract a variety of high-level transactional instructions."
Our core practice is advising and representing clients on transactions and complex corporate and commercial matters. Over the years, the practice group has built an outstanding record on headline and key transactions in Austria and throughout CEE/SEE.
Schoenherr’s m&a teams advise on national and cross-border transactions, including private m&a, public tender offers, transactions for listed companies, private equity and venture capital transactions, auction sales, privatisations, strategic alliances and joint ventures. Dedicated teams within the practice group focus on restructuring and insolvency, working together with the firm’s insolvency specialists to advise on distressed companies m&a.
Together with the firm’s regulatory specialists, the corporate/m&a group has developed industry-specific expertise covering inter alia the following sectors: energy, financial institutions, telecoms, automotive, media and pharmaceuticals.
Schoenherr’s corporate/m&a practice has consistently been ranked in the highest tier by acclaimed legal directories such as Chambers Global and Chambers Europe, IFLR1000, Legal 500 and JUVE. Among other rankings Schoenherr has been repeatedly ranked number 1 in Austria by MergerMarket rankings.
our services
- m&a
- privatisations
- public takeovers
- private equity
- venture capital
- distressed companies m&a
- sector-specific transactions, including financial institutions, energy and tmt
- start-ups
team
our team
Our international team advises on merger and acquisition matters across the CEE region.
recognised
top rankings
We are ranked in Tier 1 in Legal500 and Chambers as well as Germany's leading legal directory, JUVE magazine.
highlights
news
press release
Serbia: Schoenherr advises InPharm Co on acquisition of Casa Spadijer Bioclinica
Moravčević Vojnović and Partners in cooperation with Schoenherr advised InPharm Co, a prominent Serbian producer and distributor of dietary supplements, medical products and cosmetics, on its 100 % acquisition of Casa Spadijer Bioclinica, a local dietary supplements company.
newsletter
Navigating Hungary's ESG reporting: local subsidiaries of multinational corporations in focus
As of the 2024 financial year, companies in Hungary are facing new and stringent ESG (Environmental, Social, and Governance) reporting requirements under Act CVIII of 2023 (ESG Act). While large companies may already be familiar with the relevant EU directives (notably the CSRD and the CSDDD), the Hungarian regulations present unique challenges, especially for local subsidiaries of multinational corporations.
see all m&a news here